$ALKS: USPTO to review Alkermes Vivitrol patent

Date: Saturday, November 10th, 2018

Stock(s) mentioned:

Source: Seeking Alpha (https://seekingalpha.com)

Summary: Alkermes plc (NASDAQ:ALKS) discloses that the USPTO’s Patent Trial and Appeal Board will allow an inter partes review of 13 claims of its U.S. Patent No.

Full article address: https://seekingalpha.com/news/3408334-uspto-review-alkermes-vivitrol-patent

Related News:

$ALKS: How Should Investors React To Alkermes plc’s (NASDAQ:ALKS …

$LLY $JNJ $BIIB $ALKS: Alkermes Focuses on Pipeline, Depends on Partners for Funds

$AGN $LLY $JNJ $ALKS: Allergan’s Depression Candidate Fails in Studies, Stock Down

$ALKS: Alkermes’ Corporate Presentation to be Webcast at the Cowen and …

$ALKS $BIIB: FDA accepts Alkermes’s and Biogen’s NDA for BIIB098 for MS

$ALKS $BIIB: Alkermes and Biogen Announce US Food and Drug Administration …

$ALKS: Alkermes Public Limited Company Reminder: Pawar Law Reminds …


$ALKS: Alkermes to Present at the 8th Annual SVB Leerink Global …

$ALKS: Alkermes Breaks $1 Billion

$ALKS $CLVS: Alkermes teams up with Clovis in cancer combo treatments

Latest News:

$MCD: McDonald’s Buys Israel’s Dynamic Yield in Further Digital Push

$AME: Bull of the Day: Ametek (AME)

$IOSP $NGVT $GRA $ICL: US Chemical Output Slips in February on Broad-Based Declines

$CCL $KBH: Dow futures point to solid gains as investors keep an eye on the bond market

$AAPL: Apple Doesn’t Have Prime’s Number

$AAPL $JPM $C $ROKU $NFLX $EA: Apple Resumes Drive to $1 Trillion With Services Move Into ‘One Billion Pockets’

$AAPL: Goldman Sachs hints that Apple’s new credit card will be rolled out internationally

$MU: Samsung Sings the Chip-Making Blues

$MKC $CCL $NEOG $KBH $AAPL $GS: Apple, Samsung, McDonald’s, Uber and Careem – 5 Things You Must Know

$AXS $MMC: Insurers Creating a Consumer Ratings Service for Cybersecurity Industry

$AMZN: Don’t Just ‘Buy Now’! When Shopping on Amazon, You Need to Pay Attention